Godavari Drugs Limited (BOM:530317)

Godavari Drugs Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,050	1,134	1,567	1,596	1,611	1,227
Other Revenue	2.24	7.55	5.1	-	1.55	1.43
Revenue	1,052	1,141	1,572	1,596	1,613	1,228
Revenue Growth (YoY)	-31.89%	-27.42%	-1.50%	-1.01%	31.31%	28.26%
Cost of Revenue	753.85	828.66	1,222	1,295	1,328	978.97
Gross Profit	297.93	312.39	350.35	301.26	284.42	249.17
Selling, General & Admin	51.21	52.05	52.56	49.59	50.65	40.43
Other Operating Expenses	129.53	131.45	158.07	133.08	116.86	108.91
Operating Expenses	205.76	207.97	230.57	202.11	184.48	161.56
Operating Income	92.17	104.42	119.78	99.15	99.94	87.6
Interest Expense	-43.01	-47.32	-49.15	-39.27	-28.49	-31.89
Interest & Investment Income	-	1.06	1.07	1.29	1.1	0.8
Currency Exchange Gain (Loss)	-	-3.07	-1.58	-18.03	-2.34	1.87
Other Non Operating Income (Expenses)	0	0.82	-	3.93	-	-1.32
EBT Excluding Unusual Items	49.16	55.91	70.12	47.05	70.21	57.06
Gain (Loss) on Sale of Assets	-	0.35	-	-	-	-
Other Unusual Items	-	-	-0.9	2.3	-	-
Pretax Income	49.16	56.25	69.22	49.35	70.21	57.06
Income Tax Expense	11.26	12.45	13.73	11.49	17.75	15.78
Net Income	37.9	43.8	55.49	37.86	52.45	41.28
Net Income to Common	37.9	43.8	55.49	37.86	52.45	41.28
Net Income Growth	-40.50%	-21.07%	46.57%	-27.82%	27.06%	106.33%
Shares Outstanding (Basic)	8	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8	8
Shares Change (YoY)	0.00%	-0.04%	0.03%	0.01%	-0.10%	0.15%
EPS (Basic)	5.03	5.82	7.37	5.03	6.97	5.48
EPS (Diluted)	5.03	5.82	7.37	5.03	6.97	5.48
EPS Growth	-40.50%	-21.03%	46.52%	-27.83%	27.19%	106.01%
Free Cash Flow	-	-88.02	52.12	38.81	59.85	-3.44
Free Cash Flow Per Share	-	-11.70	6.92	5.16	7.95	-0.46
Gross Margin	28.33%	27.38%	22.28%	18.87%	17.64%	20.29%
Operating Margin	8.76%	9.15%	7.62%	6.21%	6.20%	7.13%
Profit Margin	3.60%	3.84%	3.53%	2.37%	3.25%	3.36%
Free Cash Flow Margin	-	-7.71%	3.31%	2.43%	3.71%	-0.28%
EBITDA	117.78	128.9	139.73	118.58	116.9	99.83
EBITDA Margin	11.20%	11.30%	8.89%	7.43%	7.25%	8.13%
D&A For EBITDA	25.61	24.48	19.95	19.44	16.96	12.23
EBIT	92.17	104.42	119.78	99.15	99.94	87.6
EBIT Margin	8.76%	9.15%	7.62%	6.21%	6.20%	7.13%
Effective Tax Rate	22.90%	22.14%	19.83%	23.28%	25.29%	27.66%
Revenue as Reported	1,052	1,143	1,573	1,603	1,614	1,231

Source: S&P Global Market Intelligence. Standard template. Financial Sources.